Xenetic Biosciences, Inc. (XBIO) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Xenetic Biosciences, Inc. on April 10, 2025, covering events occurring on April 8 and April 9, 2025. The Company is a Nevada corporation with principal executive offices in Framingham, Massachusetts, and its common stock trades on The Nasdaq Stock Market under the symbol "XBIO."
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The report is strictly informational regarding a change in the Company's independent registered public accounting firm.
Material Changes
The primary material change reported is the resignation of Marcum LLP as the Company's independent registered public accounting firm and the engagement of CBIZ CPAs P.C. as the successor firm.
- Resignation: Marcum LLP resigned on April 8, 2025, following the acquisition of its attest business by CBIZ CPAs P.C. on November 1, 2024. The resignation was approved by the Company's Audit Committee.
- Engagement: CBIZ CPAs P.C. was engaged on April 9, 2025, to serve as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
- Audit History: Marcum's audit reports for the fiscal years ended December 31, 2024, and 2023, were unqualified and did not contain adverse opinions, disclaimers, or modifications regarding uncertainty, scope, or accounting principles.
- Disagreements: There were no disagreements or reportable events between the Company and Marcum during the fiscal years ended December 31, 2024 and 2023, or through April 8, 2025.
- Consultations: No consultations occurred with CBIZ regarding accounting principles or audit opinions prior to their engagement.
Guidance, Outlook, and Risks
The filing contains no management guidance, financial outlook, or discussion of new risks or contingencies. The transition of the accounting firm is presented as a routine administrative change resulting from the acquisition of Marcum's business by CBIZ.
Investor Verification Checklist
- Verify the effective date of the new audit engagement with CBIZ CPAs P.C. for the 2025 fiscal year.
- Confirm that Marcum LLP's letter (Exhibit 16.1) explicitly agrees with the statements made in this 8-K regarding the absence of disagreements.
- Monitor future filings for the first audit report issued by CBIZ to ensure continuity in financial reporting standards.
- Review the Company's upcoming 10-K or 10-Q filings for any impact on the audit timeline or financial statement release dates due to the firm change.